BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW)

CUSIP: 10778Y112

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / *W EXP 02/26/202
Total 13F shares
450,000
Share change
-45,142
Total reported value
$1,125,000
Price per share
$2.50
Number of holders
2
Value change
-$111,501
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 10778Y112?
CUSIP 10778Y112 identifies BCTXW - BriaCell Therapeutics Corp. - *W EXP 02/26/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW) as of Q4 2023

As of 31 Dec 2023, BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 450,000 shares. The largest 2 holders included ARMISTICE CAPITAL, LLC and Redmond Asset Management, LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.